PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma

Cholangiocarcinoma is an aggressive biliary neoplasm lacking effective therapeutic agents. Immunotherapies targeting the PD-L1/PD-1 immune checkpoint have shown encouraging results in solid and hematologic cancers in clinical trials. Response to these immunomodulators is correlated with PD-L1 expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Fontugne, Jacqueline, Augustin, Jérémy, Pujals, Anaïs, Compagnon, Philippe, Rousseau, Benoit, Luciani, Alain, Tournigand, Christophe, Cherqui, Daniel, Azoulay, Daniel, Pawlotsky, Jean-Michel, Calderaro, Julien
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421876/
https://www.ncbi.nlm.nih.gov/pubmed/28445951
http://dx.doi.org/10.18632/oncotarget.15602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421876/
https://www.ncbi.nlm.nih.gov/pubmed/28445951
http://dx.doi.org/10.18632/oncotarget.15602

Ejemplares similares